1. Home
  2. CLSK vs IRTC Comparison

CLSK vs IRTC Comparison

Compare CLSK & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CleanSpark Inc.

CLSK

CleanSpark Inc.

HOLD

Current Price

$14.09

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$113.49

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLSK
IRTC
Founded
1987
2006
Country
United States
United States
Employees
N/A
2400
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
2008
2016

Fundamental Metrics

Financial Performance
Metric
CLSK
IRTC
Price
$14.09
$113.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
13
Target Price
$19.44
$197.92
AVG Volume (30 Days)
18.8M
620.1K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
$766,314,000.00
$747,138,000.00
Revenue This Year
N/A
$19.60
Revenue Next Year
$19.87
$15.94
P/E Ratio
N/A
N/A
Revenue Growth
102.21
26.24
52 Week Low
$8.00
$100.85
52 Week High
$23.61
$210.01

Technical Indicators

Market Signals
Indicator
CLSK
IRTC
Relative Strength Index (RSI) 48.25 45.69
Support Level $14.06 $111.37
Resistance Level $14.62 $121.88
Average True Range (ATR) 1.26 5.67
MACD -0.13 -0.72
Stochastic Oscillator 42.97 17.75

Price Performance

Historical Comparison
CLSK
IRTC

About CLSK CleanSpark Inc.

Cleanspark Inc. is a data center developer that, until recently, focused exclusively on bitcoin mining. The company provides scalable, energy-efficient digital infrastructure across the United States. The Company has a sole reporting segment, which is the bitcoin mining segment.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: